GABELLI & Co INVESTMENT ADVISERS, INC.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 932724
Rye, NY
Position in TEVA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$406,560
+$45,120 QoQ
Shares Held
12,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#416
of 671 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GABELLI & Co INVESTMENT ADVISERS, INC. holds $406,560 across 2 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
12,000 | $406,560 | |
| 2 | ESPR |
Esperion Therapeutics, Inc.
|
2,315,900 | $0 |
All Filings in TEVA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $406,560 | 12,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $361,440 | 12,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $374,520 | 12,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $303,000 | 15,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $251,400 | 15,000 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $230,550 | 15,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $330,600 | 15,000 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $270,300 | 15,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $162,500 | 10,000 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||